Fab. abvance: increasing Our Knowledge of antibody Structural Space to Enable Faster and Better Decision-Making in antibody Drug Discovery.
PDB | 5obf |
Species | MUS MUSCULUS |
Method | X-RAY DIFFRACTION |
Resolution | 1.92Å |
Number of Fvs | 1 |
In complex | True |
Light chain type | Kappa |
Has constant region | True |
|
Display options: |
This PDB has 1 Fv(s).
Fv Details | |
---|---|
Heavy chain | H |
Light chain | L |
Heavy subgroup | IGHV14 |
Light subgroup | IGKV2 |
Species | MUS MUSCULUS |
In complex? | True |
scFv? | False |
Has constant domain? | True |
Numbered Sequences (chothia) |
---|
Heavy chain
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 52A | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 82A | 82B | 82C | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E | V | Q | L | Q | Q | S | G | A | E | L | V | E | P | G | A | S | V | K | L | S | C | T | G | S | G | F | N | I | K | V | Y | Y | V | H | W | L | K | Q | L | T | E | Q | G | L | E | W | I | G | R | I | D | P | E | N | G | E | T | I | Y | T | P | K | F | Q | D | K | A | T | L | T | V | D | T | S | S | N | T | A | Y | L | Q | L | S | S | L | T | S | E | D | A | A | V | Y | Y | C | V | S | S | G | Y | W | G | Q | G | T | T | L | T | V | S | S |
Light chain
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 30A | 30B | 30C | 30D | 30E | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | I | V | M | T | Q | S | A | F | S | N | P | V | T | L | G | T | S | A | S | I | S | C | R | S | S | K | S | L | L | H | R | N | G | I | T | Y | L | Y | W | Y | L | Q | K | P | G | Q | P | P | Q | L | L | I | Y | Q | M | S | N | L | A | S | G | V | P | D | R | F | T | S | S | G | S | G | T | D | F | T | L | K | I | S | R | V | E | A | E | D | V | G | V | Y | Y | C | A | Q | N | L | E | L | W | T | F | G | G | G | T | K | L | E | I | K |
Antigen Details | |
---|---|
Antigen chains | |
Antigen type | |
Antigen name | |
Antigen species | SYNTHETIC CONSTRUCT |
Antigen sequence |
CDR Sequences (chothia definition) | |
---|---|
CDRH1 | GFNIKVY |
CDRH2 | DPENGE |
CDRH3 | SGY |
CDRL1 | RSSKSLLHRNGITYLY |
CDRL2 | QMSNLAS |
CDRL3 | AQNLELWT |
Orientation Angles (from ABangle) | |
---|---|
HL | -60.0° |
HC1 | 76.32° |
HC2 | 119.2° |
LC1 | 120.28° |
LC2 | 80.25° |
dc | 16.45Å |
Schneider, C., Raybould, M.I.J., Deane, C.M. (2022) SAbDab in the Age of Biotherapeutics: Updates including SAbDab-Nano, the Nanobody Structure Tracker. Nucleic Acids Res. 50(D1):D1368-D1372 [link]
SAbDab paper: Dunbar, J., Krawczyk, K. et al (2014). Nucleic Acids Res. 42. D1140-D1146 [link]
Thera-SAbDab paper: Raybould, M.I.J., Marks, C. et al (2019). Nucleic Acids Res. gkz827 [link]